This brand name is authorized in Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Finland, France, Hong Kong, Croatia, Italy, Lithuania, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, United States, South Africa
The drug ZOLOFT contains one active pharmaceutical ingredient (API):
1
Sertraline
UNII UTI8907Y6X - SERTRALINE HYDROCHLORIDE
|
Sertraline is a potent and specific inhibitor of neuronal serotonin (5-HT) uptake in vitro, which results in the potentiation of the effects of 5-HT in animals. It has only very weak effects on norepinephrine and dopamine neuronal reuptake. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
ZOLOFT Film-coated tablet / Oral solution | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
N06AB06 | Sertraline | N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 2236Q, 2237R, 8836C, 8837D |
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 552820020063517, 552820020063617, 552820020063717, 552820020063817, 552820020063917, 552820020064017 |
Country: CA | Health Products and Food Branch | Identifier(s): 01962779, 01962817, 02132702 |
Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 00253818, 00253830, 01041490, 01511062, 01883734, 01883740, 02711426, 02743136, 02743165, 02743975, 03497366, 03499425, 07544068, 07577837, 07577843 |
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 20.986-1-02-04, 4679-MEE-0419, 6107-MEE-0421 |
Country: EE | Ravimiamet | Identifier(s): 1008638, 1669181, 1669192, 1669204, 1669215, 1669226, 1669237, 1669248, 1669259, 1669260, 1669271, 1669282, 1669293, 1669305, 1669316, 1669327, 1831968 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 037697, 037879, 037994, 038091 |
Country: FR | Base de données publique des médicaments | Identifier(s): 60155788, 60683198 |
Country: HK | Department of Health Drug Office | Identifier(s): 36350 |
Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-153369585 |
Country: IT | Agenzia del Farmaco | Identifier(s): 027753033, 027753045, 027753108, 027753110 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1002230, 1019935, 1061976, 1061977, 1061978, 1061979, 1061980, 1061981, 1061982, 1061983, 1061984, 1061985, 1061986, 1061987, 1061988, 1061989, 1069176, 1086930, 1088370 |
Country: NG | Registered Drug Product Database | Identifier(s): 04-2796 |
Country: NL | Z-Index G-Standaard | Identifier(s): 14664992 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 39403, 59633 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 5856, 5859 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100079719, 100079725 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W67278001, W67278002, W67278003, W67278004, W67278005, W67278006, W67278007, W67278008, W67278009, W67278010, W67278011, W67278012, W67278013, W67278014, W67278015, W67278016, W67278017, W67279001, W67279002, W67279003, W67279004, W67279005, W67279006, W67279007, W67279008, W67279009, W67279010, W67279011, W67279012, W67279013, W67279014, W67279015, W67279016, W67279017, W67280001 |
Country: SG | Health Sciences Authority | Identifier(s): 07301P, 07302P |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 9243141, 9243142 |
Country: US | FDA, National Drug Code | Identifier(s): 0049-0050, 0049-4900, 0049-4910, 0049-4960, 55289-409, 70518-1913 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 32/1.2/0381 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.